OPKO Health (OPKO Health) Total Inventories

: $65.7 Mil (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

OPKO Health's total inventories for the quarter that ended in Dec. 2023 was $65.7 Mil. OPKO Health's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was $67.3 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. OPKO Health's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $-0.52.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. OPKO Health's Days Inventory for the three months ended in Dec. 2023 was 44.78.

Inventory Turnover measures how fast the company turns over its inventory within a year. OPKO Health's Inventory Turnover for the quarter that ended in Dec. 2023 was 2.04.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. OPKO Health's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.37.

OPKO Health Total Inventories Historical Data

The historical data trend for OPKO Health's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

53.43

132.34

86.50

74.06

65.70

OPKO Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Inventories																74.06	75.41	73.75	68.96	65.70

OPKO Health Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

OPKO Health (NAS:OPK) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

OPKO Health's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(95.881	+	0.75 * 123.379	+	0.5 * 65.697	-	622.479
-	0	-	0)	/	773.282
=	-0.52

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

OPKO Health's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	67.3285	/	137.197	*	365 / 4
	=	44.78

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

OPKO Health's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	137.197	/	67.3285
	=	2.04

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

OPKO Health's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	67.3285	/	181.904
	=	0.37

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

OPKO Health Total Inventories Related Terms

Thank you for viewing the detailed overview of OPKO Health's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

OPKO Health (OPKO Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (NAS:OPK) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

OPK:Mexico OPK:Israel XCY:Germany XCY:Germany

Address

4400 Biscayne Boulevard, Miami, FL, USA, 33137

Website

https://www.opko.com

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.

Executives

Frost Phillip Md Et Al	10 percent owner	4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Hsiao Jane Ph D	director	4400 BISCAYNE BLVD, MIAMI FL 33137
Gary J. Nabel	director, officer: Chief Innovation Officer	C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Elias A. Zerhouni	director, officer: Vice Chairman and President	2099 PENNSYLVANIA AVENUE, NW 12TH FLOOR, WASHINGTON DC 20006
John A Paganelli	director, other: Chairman of the Board	OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Steven D Rubin	director	OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Pfenniger Richard C Jr	director	4400 BISCAYNE BLVD., MIAMI FL 33137
Alexis Borisy	director	C/O COMBINATORX, INCORPORATED, 245 FIRST STREET, 16TH FLOOR, CAMBRIDGE MA 02142
Jon R Cohen	director, officer: SVP OPKO; Exec Chairman BRLI	C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Prem A Lachman	director	4400 BISCAYNE BLVD., MIAMI FL 33137
Roger Md Medel	director	1301 CONCORD TERRACE, SUNRISE FL 33323
Rulfo Fernando Hernandez	officer: CAO, Treasurer	C/O OPKO HEALTH INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Anthony J Japour	director	19805 N. CREEK PARKWAY, BOTHELL WA 98011
Robert Scott Fishel	director	C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Adam Logal	officer: Exec.Dir .of Fin., CAO,Treas.	OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137